This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.
The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.
In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Report Includes
- 44 data tables and 30 additional tables
- An overview of the global market for blood plasma products
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
- Detailed information related to mode of delivery for blood plasma
- Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
- Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
- In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
- A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
- Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4 What's New in this Update?
1.5 Information Sources
1.6 Methodology
1.7 Intended Audience
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 Custom Research
1.11 Related Research Reports
Chapter 2 Summary and Highlights
2.1 Highlights of the Market for Blood Plasma Products
Chapter 3 Market and Technology Background
3.1 Introduction to Blood Plasma Products
3.2 Components of Blood Plasma
3.3 Functions of Blood Plasma
3.4 Blood Donation
3.4.1 Collection and Extraction of Blood Plasma
3.4.2 Fractionation Methods for Extracting Individual Components from Plasma
3.5 Government Regulations: Fda, International Regulatory Agencies and Medical Associations
3.6 Clinical Guidelines
3.7 Market Dynamics
3.7.1 Drivers
3.7.2 Restraints
3.7.3 Opportunities
Chapter 4 Market Breakdown by Product Type
4.1 Overall Market Size and Forecast
4.2 Immunoglobulins
4.2.1 Market Size and Forecast by Region
4.2.2 Market Size and Forecast by Product Subsegment
4.3 Albumin
4.3.1 Market Size and Forecast by Region
4.4 Coagulation Factor Concentrates
4.4.1 Market Size and Forecast by Region
4.5 Hyperimmune Globulins
4.5.1 Market Size and Forecast by Region
4.6 Other Plasma Fractionation Products
4.6.1 Market Size and Forecast by Region
Chapter 5 Market Breakdown by Application
5.1 Overall Market Size and Forecast
5.2 Neurology
5.2.1 Market Size and Forecast by Region
5.3 Immunology
5.3.1 Market Size and Forecast by Region
5.4 Oncology
5.4.1 Market Size and Forecast by Region
5.5 Transplants
5.5.1 Market Size and Forecast by Region
5.6 Hematology
5.6.1 Market Size and Forecast by Region
5.7 Rheumatology
5.7.1 Market Size and Forecast by Region
5.8 Pulmonology
5.8.1 Market Size and Forecast by Region
5.9 Others
5.9.1 Market Size and Forecast by Region
Chapter 6 Market Breakdown by End-user
6.1 Overall Market Size and Forecast
6.2 Hospitals and Clinics
6.2.1 Market Size and Forecast by Region
6.3 Research Laboratories
6.3.1 Market Size and Forecast by Region
6.4 Academic Institutions
6.4.1 Market Size and Forecast by Region
6.5 Blood Transfusion Centers
6.5.1 Market Size and Forecast by Region
Chapter 7 Market Breakdown by Region
7.1 Overall Market Size and Forecast by Region
7.2 North America
7.2.1 North American Market Size and Forecast by Country
7.2.2 North American Market Size and Forecast by Product Type
7.2.3 North American Market Size and Forecast by Application
7.2.4 North American Market Size and Forecast by End-user
7.3 Europe
7.3.1 European Market Size and Forecast by Country
7.3.2 European Market Size and Forecast by Product Type
7.3.3 European Market Size and Forecast by Application
7.3.4 European Market Size and Forecast by End-user
7.4 Asia-Pacific
7.4.1 Asia-Pacific Market Size and Forecast by Country
7.4.2 APAC Market Size and Forecast by Product Type
7.4.3 APAC Market Size and Forecast by Application
7.4.4 APAC Market Size and Forecast by End-user
7.5 Rest of the World
7.5.1 Rest of the World Market Size and Forecast by Country
7.5.2 Row Market Size and Forecast by Product Type
7.5.3 Row Market Size and Forecast by Application
7.5.4 Row Market Size and Forecast by End-user
Chapter 8 Mode of Delivery for Blood Plasma Products
8.1 Infusion Solutions
8.2 Gels
8.3 Sprays
8.4 Biomedical Sealants
8.5 Other Modes of Delivery
8.5.1 Inhalation
8.5.2 Ophthalmic Drops
Chapter 9 Patent Review and Clinical Trial Landscape
9.1 Patent Review
9.2 Clinical Trials Landscape
Chapter 10 Impact of the Covid-19 Pandemic on the Market for Blood Plasma Products
10.1 Impact on the Blood Plasma Product Manufacturers
Chapter 11 Competitive Landscape
11.1 Overview
11.2 Major Players and Market Shares
11.3 Porter's Five Forces Analysis of the Market for Blood Plasma Products
11.3.1 Bargaining Power of Suppliers
11.3.2 Bargaining Power of Buyers
11.3.3 the Threat of New Suppliers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry/Degree of Competition
11.4 Major Developments
11.5 Product Launches
11.6 Mergers and Acquisitions
11.7 Business Expansions
11.8 Agreements and Collaborations
Chapter 12 Company Profiles
- Adma Biologics Inc.
- Baxter International
- Bio Products Laboratory Ltd. (Bpl)
- China Biologic Products Inc.
- Csl Behring
- Grifols International Sa
- Innovative Research Inc.
- Intas Pharmaceuticals Ltd.
- Kedrion Spa
- Lfb Sa
- Octapharma AG
- Sanquin
- Takeda Pharmaceutical Co. Ltd.
List of Tables
Summary Table: Global Market for Blood Plasma Products, by Product Type, Through 2027
Table 1: Blood Plasma Components
Table 2: Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 3: Overview of Plasma Collection Operations Across Various Countries
Table 4: Global Market for Blood Plasma Products, by Product Type, Through 2027
Table 5: Global Market for Immunoglobulins, by Region, Through 2027
Table 6: Global Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 7: Global Market for Intravenous Immunoglobulin, by Region, Through 2027
Table 8: Global Market for Subcutaneous Immunoglobulins, by Region, Through 2027
Table 9: Global Market for Other Immunoglobulins, by Region, Through 2027
Table 10: Global Market for Albumins, by Region, Through 2027
Table 11: Global Market for Coagulation Factor Concentrates, by Region, Through 2027
Table 12: Global Market for Hyperimmune Globulins, by Region, Through 2027
Table 13: Key Protease Inhibitors Used in the Treatment of HIV
Table 14: Global Market for Other Plasma Fractionation Products, by Region, Through 2027
Table 15: Global Market for Blood Plasma Products, by Application, Through 2027
Table 16: Global Market for the Application of Blood Plasma Products in Neurology, by Region, Through 2027
Table 17: Global Market for the Application of Blood Plasma Products in Immunology, by Region, Through 2027
Table 18: Global Market for the Application of Blood Plasma Products in Oncology, by Region, Through 2027
Table 19: Global Market for the Application of Blood Plasma Products in Transplants, by Region, Through 2027
Table 20: Global Market for the Application of Blood Plasma Products in Hematology, by Region, Through 2027
Table 21: Global Market for the Application of Blood Plasma Products in Rheumatology, by Region, Through 2027
Table 22: Global Market for the Application of Blood Plasma Products in Pulmonology, by Region, Through 2027
Table 23: Global Market for the Application of Blood Plasma Products in Other Areas, by Region, Through 2027
Table 24: Global Market for Blood Plasma Products, by End User, Through 2027
Table 25: Global Market for Blood Plasma Products Used in Hospitals and Clinics, by Region, Through 2027
Table 26: Global Market for Blood Plasma Products Used in Research Laboratories, by Region, Through 2027
Table 27: Global Market for Blood Plasma Products Used in Academic Institutions, by Region, Through 2027
Table 28: Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2027
Table 29: Global Market for Blood Plasma Products, by Region, Through 2027
Table 30: North American Market for Blood Plasma Products, by Country, Through 2027
Table 31: North American Market for Blood Plasma Products, by Product Type, Through 2027
Table 32: North American Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 33: North American Market for Blood Plasma Products, by Application, Through 2027
Table 34: North American Market for Blood Plasma Products, by End User, Through 2027
Table 35: European Patients in Need of Plasma Protein Therapies
Table 36: European Market for Blood Plasma Products, by Country, Through 2027
Table 37: European Market for Blood Plasma Products, by Product Type, Through 2027
Table 38: European Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 39: European Market for Blood Plasma Products, by Application, Through 2027
Table 40: European Market for Blood Plasma Products, by End User, Through 2027
Table 41: Asia-Pacific Market for Blood Plasma Products, by Country, Through 2027
Table 42: Asia-Pacific Market for Blood Plasma, by Product Type, Through 2027
Table 43: Asia-Pacific Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 44: Asia-Pacific Market for Blood Plasma Products, by Application, Through 2027
Table 45: Asia-Pacific Market for Blood Plasma Products, by End User, Through 2027
Table 46: Rest of the World Market for Blood Plasma Products, by Product Type, Through 2027
Table 47: Rest of the World Market for Immunoglobulins, by Product Subsegment, Through 2027
Table 48: Rest of the World Market for Blood Plasma Products, by Application, Through 2027
Table 49: Rest of the World Market for Blood Plasma Products, by End User, Through 2027
Table 50: Key Patents Filed on Various Blood Plasma Products, by Competitor Companies, 2019-2022
Table 51: Clinical Trial Activities of Key Competitors on Various Blood Plasma Products
Table 52: Porter’s Five Forces Analysis: Global Market for Blood Plasma Products
Table 53: Product Launches in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 54: Mergers and Acquisitions of Key Competitors in the Global Market for Blood Plasma Products, 2020-2022
Table 55: Business Expansion Activities in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 56: Agreements and Collaborations Activities in the Global Market for Blood Plasma Products, by Key Competitors, 2020-2022
Table 57: ADMA Biologics Inc.: Product Portfolio
Table 58: ADMA Biologics Inc.: Developments and Strategies, 2022
Table 59: Bio Products Laboratory Ltd.: Product Portfolio
Table 60: Bio Products Laboratory Ltd.: Developments and Strategies, 2021 and 2022
Table 61: China Biologic Products Inc.: Product Portfolio
Table 62: China Biologic Products Inc.: Developments and Strategies, 2020
Table 63: CSL Behring: Product Portfolio
Table 64: CSL Behring: Developments and Strategies, 2021 and 2022
Table 65: Grifols International SA: Product Portfolio
Table 66: Grifols International SA: Developments and Strategies, 2020-2022
Table 67: Kedrion SpA: Product Portfolio
Table 68: Kedrion SpA: Developments and Strategies, 2020-2022
Table 69: LFB SA: Developments and Strategies, 2021 and 2022
Table 70: Octapharma AG: Product Portfolio
Table 71: Octapharma AG: Developments and Strategies, 2021 and 2022
Table 72: Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 73: Takeda Pharmaceutical Co. Ltd.: Developments and Strategies, 2022
List of Figures
Summary Figure: Global Market for Blood Plasma Products, by Product Type, 2019-2027
Figure 1: Role of Albumin Concentration in Maintaining Osmotic Pressure
Figure 2: Benefits of Blood Donation to the Donor
Figure 3: Supply Chain of Blood Plasma Products Market
Figure 4: FDA Regulation for Approval of Blood Products and Devices
Figure 5: Global Market for Blood Plasma Products, by Product Type, 2019-2027
Figure 6: Global Market Shares of Blood Plasma Products, by Product Type, 2021
Figure 7: Subsegments of the Market for Immunoglobulin Products
Figure 8: Global Market Shares of Immunoglobulins, by Region, 2021
Figure 9: Global Market Shares of Immunoglobulins, by Product Subsegment, 2021
Figure 10: Global Market Shares of Intravenous Immunoglobulin, by Region, 2021
Figure 11: Categorization of Subcutaneous Immunoglobulin
Figure 12: Global Market Shares of Subcutaneous Immunoglobulins, by region, 2021
Figure 13: Global Market Shares of Other Immunoglobulins, by Region, 2021
Figure 14: Global Market Shares of Albumins, by Region, 2021
Figure 15: Global Market Shares of Coagulation Factor Concentrates, by Region, 2021
Figure 16: Process of the Isolation of Hyperimmune Globulin
Figure 17: Global Market Shares of Hyperimmune Globulins, by Region, 2021
Figure 18: Global Market Shares of Other Plasma Fractionation Products, by Region, 2021 (%)
Figure 19: Global Market for Blood Plasma Products, by Application, 2019-2027
Figure 20: Global Market Shares of Blood Plasma Products, by Application, 2021
Figure 21: Role of Plasma Exchange in the Treatment of Neuroimmunological Disorders
Figure 22: Functions of the Immune System
Figure 23: Conditions Engendering Blood Transfusions
Figure 24: Categories of Bleeding Disorders
Figure 25: Symptoms of Lupus Infection
Figure 26: Global Market Shares of Blood Plasma Products, by End User, 2021
Figure 27: Role of Platelet-Rich Plasma in Treatment
Figure 28: Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2027
Figure 29: Global Market for Blood Plasma Products, by Region, 2019-2027
Figure 30: Global Market Shares of Blood Plasma Products, by Region, 2021
Figure 31: North American Market Shares of Blood Plasma Products, by Country, 2021
Figure 32: U.S. Market for Blood Plasma Products, 2019-2027
Figure 33: Canadian Market for Blood Plasma Products, 2019-2027
Figure 34: European Market for Blood Plasma Products, by Country, 2019-2027
Figure 35: European Market Shares of Blood Plasma Products, by Country, 2021
Figure 36: German Market for Blood Plasma Products, 2019-2027
Figure 37: French Market for Blood Plasma Products, 2019-2027
Figure 38: Italian Market for Blood Plasma Products, 2019-2027
Figure 39: U.K. Market for Blood Plasma Products, 2019-2027
Figure 40: Rest of the European Market for Blood Plasma Products, 2019-2027
Figure 41: Asia-Pacific Market for Blood Plasma Products, by Country, 2019-2027
Figure 42: Asia-Pacific Market Shares of Blood Plasma Products, by Country, 2021
Figure 43: Japanese Market for Blood Plasma Products, 2019-2027
Figure 44: Chinese Market for Blood Plasma Products, 2019-2027
Figure 45: Indian Market for Blood Plasma Products, 2019-2027
Figure 46: Australian Market for Blood Plasma Products, 2019-2027
Figure 47: Rest of Asia-Pacific Market for Blood Plasma Products, 2019-2027
Figure 48: Rest of the World Market for Blood Plasma Products, 2019-2027
Figure 49: Frequent Side Effects Associated with Immunoglobulin Infusions
Figure 50: Rarely Induced Severe Allergic Reactions Associated with Immunoglobulin Infusions
Figure 51: Procedure for Plasma Gel Treatment
Figure 52: Role of Fibrin Sealant in Coagulation Cascade
Figure 53: Global Market Shares of Blood Plasma Products, by Company, 2021
Figure 54: ADMA Biologics Inc.: Financials, 2020 and 2021
Figure 55: ADMA Biologics Inc.: Revenue Share, by Business Segment, 2021
Figure 56: ADMA Biologics Inc.: Market Shares, by Region, 2021
Figure 57: CSL Behring: Annual Revenue, 2019-2021
Figure 58: CSL Behring: Market Shares, by Region, 2021
Figure 59: Grifols International SA: Financials, 2019-2021
Figure 60: Grifols International SA.: Market Share, by Business Segment, 2021
Figure 61: Grifols International SA.: Market Share, by Region, 2021
Figure 62: Kedrion SpA: Financials, 2019-2021
Figure 63: Kedrion SpA: Revenue Share, by Business Segment, 2021
Figure 64: Kedrion SpA: Market Share, by Region, 2021
Figure 65: Octapharma AG: Financials, 2019-2021
Figure 66: Takeda Pharmaceutical Co. Ltd.: Financials, 2020 and 2021
Figure 67: Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Region, 2021
Figure 68: Takeda Pharmaceutical Co. Ltd.: Revenue Share, by Business Segment, 2021
Executive Summary
This report segments the global market by product type, application, end user and region.
Reasons for Doing This Study:
Plasma, the largest component of blood, accounts for 55% of total blood composition. Plasma consists of various components such as water, electrolytes, albumin and immunoglobulins, among others. Each component of blood plasma performs a different function in the body and plays a vital role in ensuring the effective performance of other body organs. Additionally, plasma serves as a carrier for nutrients and hormones as well as the proteins that transport these components throughout the body. Blood plasma is a major source of immunoglobulins and is used in the treatment of patients suffering from immunoglobulin deficiency. Exploring the potential of blood plasma in the large-scale treatment of immuno-compromised patients has become essential with the emerging incidences of primary as well as secondary immunodeficiencies. An increase in the cases of bleeding disorders such as hemophilia A, hemophilia B and von Willebrand disease has resulted in a better understanding of blood plasma and its potential in the treatment of these diseases. Hence, the study of blood plasma products helps improve the understanding of blood plasma and the potential of using blood plasma therapies in chronic disease management. The report will highlight the latest developments in the application of recombinant products.
This report provides the latest, critical and complete information as well as a detailed analysis of market opportunities in the blood plasma products market for all members of the intended audience
Companies Mentioned
- Adma Biologics Inc.
- Baxter International
- Bio Products Laboratory Ltd. (Bpl)
- China Biologic Products Inc.
- Csl Behring
- Grifols International Sa
- Innovative Research Inc.
- Intas Pharmaceuticals Ltd.
- Kedrion Spa
- Lfb Sa
- Octapharma AG
- Sanquin
- Takeda Pharmaceutical Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 144 |
| Published | February 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 33.2 Billion |
| Forecasted Market Value ( USD | $ 45.7 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
